Tag: TAVI

ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

Edoxaban is noninferior to warfarin and its analogues for adverse clinical events in patients wi...

Two-year Evolut Low Risk trial data shows “very favourable outcomes” for TAVI compared with SAVR

 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk about the full two-yea...

EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...

SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

Medtronic has announced results from an interim analysis of the first 171 patients (including 71...

PCR e-Course 2020: Evolut Low-Risk trial confirms TAVI is non-inferior to surgery, and establishes it is cost-effective

Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findings from the study, d...

Keith Oldroyd to become CMO at Biosensors

Biosensors International Group has announced the appointment of Keith G Oldroyd to the post of c...

Transcatheter heart valves are overlapping with coronary arteries

Data from a pilot imaging study of commissural alignment in trancatheter aortic valve implantati...

TriGUARD 3 given CE mark for embolic protection during TAVI

European CE mark has been awarded to the TriGUARD 3 cerebral embolic protection (CEP) device fro...

ACURATE neo helps facilitate early discharge following TAVI procedures

NOTE: This video is ONLY available to watch in selected countries and geographies Rajesh ...

CRT 2020: Stage 3 kidney injury after TAVI leads to seven times higher mortality

Patients who develop stage 3 acute kidney injury (AKI) following transcatheter aortic valve impl...

Self-expanding and balloon-expandable valves are equally effective in high-risk TAVI

A comparison of newer generation self-expanding valves (SEV) and balloon-expandable valves (BEV)...

STS 2020: Young patients with aortic valve disease do better with SAVR than TAVI

Open heart surgery remains the best option for young and middle-aged adults with aortic valve di...

Selecting the right valve for the patient is key for a successful TAVI program

NOTE: This video is ONLY available to watch in selected countries and geographies

Low albumin, anaemia, and slow walking speed predict mortality after TAVI

The largest study to date of the role of frailty indices after transcatheter aortic valve implan...
SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

Emboline completes enrolment in SAFEPASS 2 clinical trial

Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emboliner embolic prote...

Self-expanding valves show good haemodynamic performance in small annuli

A retrospective registry comparing four self-expanding transcatheter heart valves has demonstrat...

Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial sess...

PCR London Valves 2019: Meril unveils positive data for Myval

Meril has announced positive data on its Myval Transcatheter Heart Valve System at PCR London Va...

PCR London Valves 2019: A simple algorithm can reduce unnecessary pacemaker implantation after TAVI

Permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) is assoc...

Pre-TAVI aortic regurgitation aids survival post-TAVI in mixed aortic valve disease patients

Patients who have mixed aortic valve disease with pre-existing aortic regurgitation have better ...

Admedus sells CardioCel and VacsuCel to focus on TAVI

Admedus has sold the distribution rights to its CardioCel and VascuCel product range for $A36.2 ...

TCT 2019: Safety and efficacy of Portico valve noninferior to FDA-approved TAVI systems

The Portico IDE study has found that 30-day safety and one-year effectiveness outcomes of a nove...

ADVERTORIAL: Device and procedural innovations have led to improved efficiency with TAVI

Caution: This content is only for readers outside of France and Japan. In the US, ACURATE neo is...

Age alone should not preclude TAVI in patients aged ≥90 years

The clinical frailty score currently used to assess suitability for transcatheter aortic valve i...

SAVR has lower mortality and MACCE than TAVI using first-generation devices in low- and intermediate-risk patients after five years

Five-year results suggest that surgical aortic valve replacement (SAVR) is associated with lower...

FEops HEARTguide wins CSI Highlight of the Year Award

FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its FEops HEARTguide unde...

NICE issues recommendations on insertion of cerebral protection devices during TAVI

The National Institute for Health and Care Excellence (NICE) has released evidence-based recommendat...

PCR statement on TAVI signals “paradigm shift” in treatment of severe symptomatic AS

Evolving indications for the use of transcatheter aortic valve implantation (TAVI) have led to a...

ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

Evidence for the use of transcatheter aortic valve replacement (TAVI) as standard therapy is mountin...

Shockwave Intravascular Lithotripsy (IVL) helps facilitate first-choice transfemoral access for TAVR

 Carlo Di Mario (Florence, Italy) tells Cardiovascular News at CRT 2019 that there is “incredibl...

SCCT releases new guideline for use of computed tomography in TAVR procedure

The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus doc...

Combination of high-sensitive C-reactive protein with logistic EuroSCORE improves risk stratification in TAVI patients

According to Anja Stundl (Department of Medicine II, Heart Center Bonn, University Hospital, Bon...

SCAI 2018: 3D model could be used to predict paravalvular leak after TAVI

A new study presented at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI...

TAVI is increasingly seen as the preferred approach for aortic valve replacement in CABG patients

A review of the trends in the use and propensity-matched analysis of in-hospital outcomes, publi...

“Favourable” in-hospital outcomes for younger patients undergoing TAVI

Registry data for younger patients—under 75 years—undergoing transcatheter aortic valve implanta...

Depression significantly increases mortality after aortic valve replacement

Data from the FRALITY-AVR (Frality aortic valve replacement) study suggest that the presence of ...

Next-day discharge appears safe for TAVI patients without in-hospital complications

Patients who undergo transfemoral transcatheter aortic valve implantation (TAVI) with a minimali...

Modifying procedural technique during TAVI may lower radiation exposure to patients

Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Center, Omaha, USA) and...

Claret Medical closes on series C financing of US$14.5m

Claret Medical has announced that it has closed on a series C financing of US$14.5m led by Light...

Relatively few chronic kidney disease patients require dialysis after TAVI

James W Hansen (Lahey Hospital and Medical Center, Burlington, USA) and others report in JACC: C...

No significant differences in post TAVI outcomes between African Americans and Caucasians

Fahad Alqahtani (Division of Cardiology, West Virginia University Heart & Vascular Institute...

All-comers data indicate stroke-free survival is improved with Sentinel embolic protection device

Jochen Wöhrle (Department of Internal Medicine II, Cardiology, University of Ulm, Ulm, Germany) ...

ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event

Of 5,691 adverse events following transcatheter aortic valve implantation (TAVI) that were repor...

ProtEmbo cerebral protection system used for first time

The ProtEmbo cerebral protection system (Protembis) has been used, to complement a transcatheter...

CE mark for CoreValve Evolut Pro

Medtronic has received the CE mark for its CoreValve Evolut Pro valve for the treatment of sever...

EuroPCR 2017: A “golden era” for valve disease therapies

At this year’s EuroPCR (16–19 May, Paris, France), Philip MacCarthy writes, I had the pleasure o...

Embolic protection device company raises US$5million in series B financing for advanced device development and initiation of US clinical activities

Innovative Cardiovascular Solutions has announced today completion of an oversubscribed Series B...

CoreValve Evolut can be used to treat intermediate-risk patients in the USA

Medtronic has announced that the FDA has approved the company’s self-expanding transcatheter aor...

Essential Frailty Toolset may be best assessment of frailty for aortic stenosis patients

Jonathan Afilalo (Division of Cardiology, Jewish General Hospital, McGill University, Montreal, ...

Unique 3D-printed heart valves could reduce TAVI paravalvular leakage rates

Researchers at Georgia Institute of Technology and the Piedmont Heart Institute (both Atlanta, USA) ...

Nearly one in 10 US TAVI procedures is off label but results seem acceptable

Ravi S Hira (Section of Cardiology, University of Washington, Seattle, USA) and others report in...

EuroPCR 2017: Study provides “first step” towards showing long-term durability of TAVI devices

New data presented, by Luca Testa (Department of Cardiology, IRCCS Policlinico S. Donato, Milan,...

Study confirms that volume matters for achieving lower in-hospital mortality after TAVI

A study, published in EuroIntervention, provides further evidence that there is an inverse relat...

Bicuspid aortic stenosis: TAVI’s next challenge

Most of the initial registries, and the large randomised trials, for transcatheter aortic valve ...

EuroPCR 2017: Greater risks with standard approach of dual antiplatelet therapy after TAVI

The ARTE study, which was simultaneously presented at EuroPCR (16–19 May, Paris, France) and pub...

TVT 2017: Presentation showcases safety of Tempo temporary pacing lead

BioTrace Medical announced that its Tempo temporary pacing lead was featured in an oral presenta...

US centres of TAVI excellence start to use newly approved Sentinel device

Claret Medical has announced that several of the largest centres of excellence for transcatheter...

HLT’s TAVI system implanted in first US patients

The first patients in an early feasibility study of HLT’s transcatheter aortic valve implantation (T...

TVT 2017: “I predict a very exciting and bright future” for transcatheter valve therapies

This year marks the 10th anniversary of the Transcatheter Valve Therapies (TVT) meeting (14–17 J...

Sentinel becomes first cerebral protection device to receive FDA approval

Claret Medical has received regulatory clearance from the FDA for its Sentinel cerebral protecti...

EuroPCR 2017: Excellent early outcomes for Edwards Lifesciences’ self-expanding valve

According to late-breaking trial presented at EuroPCR (16–19 May, Paris, France), a novel self-e...

EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year

Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAV...

Boston Scientific closes Symetis acquisition

Boston Scientific Corporation has announced the close of its acquisition of Symetis SA, a privat...

The role of nurses in ensuring a patient-focused TAVI service

Preadmission clinics for patients awaiting elective procedures or surgery are not a new concept....

Reduced baseline left ventricular function may explain female survival benefit after TAVI

A new study indicates that the apparent survival benefit after transcatheter aortic valve implan...

Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in atrial fibrillation undergoing TAVI

The ENVISAGE-TAVI AF is the first study to evaluate the effects of a novel oral anticoagulant on...

Meta-analysis supports transaortic approach in TAVI

A meta-analysis of single-centre studies indicates that the use of the transaortic appraoch in p...

First patients enrolled in HLT’s Meridian transcatheter aortic valve feasibility study

HLT has announced that the first patient implants in a feasibility clinical study to assess the safe...

CE mark granted to NVT for Allegra transcatheter aortic valve

NVT has received the CE mark for its Allegra transcatheter aortic valve, which it describes as “...

Boston Scientific agrees to acquire Symetis

Boston Scientific Corporation have definitively agreed to acquire Symetis, a privately-held Swiss st...

TAVI pacemaker issue is “an engineering problem that will be solved”

The SURTAVI trial indicates that transcatheter aortic valve implantation (TAVI)  with CoreValve/...

ACC 2017: FDA approves launch of CoreValve Evolut Pro

The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (T...

ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment

Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarte...

TAVI may benefit certain heart valve patients, update society guidelines say

New recommendations have been published by the American Heart Association and the American College o...

ACC 2017: No significant differences in two-year morality between bicuspid and tricuspid aortic stenosis patients undergoing TAVI

Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal ...

ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients

Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessi...

Innovative Cardiovascular Solutions announces successful first use of its Emblok embolic protection system

  Innovative Cardiovascular Solutions has announced the successful first European clinic...

Early hospital discharge after TAVI less likely in women

A study, published in the Journal of Interventional Cardiology, indicates that females, bleeding...

Valve replacement may better than vavluloplasty for aortic stenosis patients with end-stage renal disease

A new study published in Catheterization and Cardiovascular Interventions indicates that valve r...

FDA advisory panel recommend de novo approval of Sentinel cerebral protection system

In an open public hearing of the FDA’s circulatory system devices panel, according to a press re...

Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device

According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valv...

New guidelines released to improve stroke reporting following cardiac procedures

In response to a growing body of evidence of the existence of "covert" brain injury to patients ...

Meta-analysis indicates embolic protection does reduce stroke after TAVI

In a research letter published in the Journal of the American College of Cardiology, Gennaro Giu...

Positive results for heart surgery in elderly aortic stenosis patients

Elderly patients with aortic stenosis and medium surgical risk experienced better than expected resu...

Left atrial appendage thrombus may increase the risk of stroke after TAVI

Sonny Palmer (St Vincent’s Hospital, Melbourne, Australia) and others report in JACC: Cardiovasc...

Medtronic receives CE mark for 34mm size CoreValve Evolut R

The CE mark has been granted to Medtronic for the 34mm-valve version of its CoreValve Evolut R, ...

TAVI company Direct Flow Medical closes after failing to secure funding

Direct Flow Medical, which markets a CE-marked transcatheter aortic valve implantation (TAVI) device...

The management of leaflet thickening after TAVI remains controversial

Ryo Yanagisawa (Department of Cardiology, Keio University School of Medicine, Tokyo, Japan) and ...

New AHA/ACC guidance released for TAVI

A new expert consensus decision pathway will assist clinicians and hospitals in assessing patients’ ...

Perform PCI prior to TAVI in patients with both coronary artery disease and aortic stenosis

Stephen Ramee (Ochsner Medical Center, New Orleans, USA) and others outline in a paper in JACC: ...

Women fare better than men one year after transcatheter aortic valve implantation

Women with significant aortic valve disease who undergo transcatheter aortic valve implantation ...

Minimally invasive TAVI has “several potential benefits”

Recently, there has been a move towards transcatheter aortic valve implantation (TAVI) procedure...

Pacemaker after TAVI is associated with worse outcomes

A study in JACC: Cardiovascular Interventions indicates that patients who require a pacemaker after ...

NICE should develop heart valve guidelines says Heart Valve Voice

UK charity Heart Valve Voice has launched a report—Towards a Heart Healthy Future: a 2020 Vision for...

TCT 2016: SENTINEL trial fails to meet overall primary efficacy endpoint but does in adjusted model

The SENTINEL trial, which was presented at the 2016 Transcatheter Cardiovascular Therapeutics (T...

TCT 2016: Positive real-world data for CoreValve Evolut R presented

Today, Medtronic presented new positive data from two large registries aimed at evaluating 30-da...

FDA clear temporary pacing lead for use during TAVI and other cardiovascular applications

BioTrace Medical has received FDA 510(k) clearance for its Tempo Lead, which a press release des...

TAVI is “technically feasible” for managing aortic regurgitation in high-risk patients

Anna Franzone (Department of Cardiology, Swiss Cardiovascular Center, University Hospital, Bern,...

TAVI at the end of life: Knowing when it is futile

Understanding how aggressively to treat patients in their last years of life is challenging for ...

Simplified TAVI device may benefit patients with rheumatic heart disease

At the South Africa Heart Association annual congress (8–11 September, Cape Town, South Africa),...

PCRLV 2016: New approaches to TAVI are still being explored

Although much of the innovation in transcatheter solutions for structural heart disease is now f...

TriGuard cerebral protection associated with significant improvements in brain protection in TAVI patients

Preliminary real-world findings, presented at PCR London Valves (18–20 September, London, UK), i...

Claret Medical submits application for FDA approval of its cerebral protection device

Claret Medical has announced its filing of a marketing application with the FDA for clearance of...

Sapien 3 now approved for intermediate-risk patients in Europe as well as in the USA

Following last month’s FDA approval for the expanded indication of Sapien 3 for the treatment of...

PCRLV 2016: Next-generation of Lotus TAVI receives CE mark

Coinciding with PCR London Valves (18-20 September, London, UK), Boston Scientific has announced...

TCT 2016: Pivotal trial on cerebral protection device to be presented as a late-breaker

Data from the SENTINEL pivotal IDE trial will be presented during a late-breaking trial session ...

Redo TAVI procedures are safe and feasible

Marco Barbanti (Ferrarotto Hospital, University of Catania, Catania, Italy) and others report in...

“Keep it fast and simple” to avoid periprocedural stroke after TAVI

At PCR London Valves (18–20 September, London, UK), Holger Eggebrecht (Cardioangiological Center...

Vivasure Medical secures €16.2 million series C financing

Vivasure Medical has announced that the company has completed a series C financing of €16.2 million....

Edwards Sapien 3 granted expanded indication from US FDA

Edwards Lifesciences has announced US Food and Drug Administration (FDA) approval to expand use ...

CE mark granted to InSeal Medical for InClosure vascular closure device

InSeal Medical has received CE mark approval for its InClosure VCD; a large bore vascular closur...

Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.

Boston Scientific has sent a letter to its customers notifying them that it is implementing a “v...

Medtronic CoreValve Evolut becomes first TAVI to receive CE mark for intermediate risk aortic stenosis patients

Medtronic has received CE marking for the self-expanding, recapturable and repositionable CoreValv...

What is required for TAVI to become the new gold standard?

Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) ha...

TAVI with Sapien 3 may be better than surgery for intermediate-risk patients

A ccording to Vinod H Thourani (Emory University School of Medicine, Atlanta, USA...

Moderate sedation during TAVI associated with significantly better outcomes

Jay Giri (Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Phil...